Share on linkedin Data: American Society of Health-System Pharmacists; Note: Each point represents the number of active shortages at the end of each quarter; Chart: Axios Visualshave risen to their highest level since the American Society of Health-System Pharmacists began tracking in 2001.This high-water mark should energize efforts in Congress and federal agencies to address the broken market around what are often critical generic drugs, the organization says.
Drugmakers that can demonstrate safer, higher-quality manufacturing practices should earn a higher price, he said. Manufacturing quality concerns in particular have fueled shortages of chemotherapy drugs and some antibiotics.Controlled substances, such as pain and sedation medications,12% of active shortages, which are tied to recent legal settlements and Drug Enforcement Administration changes to production limits, per ASHP.
Not surprisingly, the blockbuster category of anti-obesity drugs known as GLP-1s are in shortage largely because of outsized demand.